Edgewood Oncology, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2023-01-01
- Employees
- 1
- Market Cap
- -
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- First Posted Date
- 2021-05-04
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Edgewood Oncology Inc.
- Target Recruit Count
- 112
- Registration Number
- NCT04872166
- Locations
- 🇺🇸
Florida Cancer Specialists, Sarasota, Florida, United States
🇺🇸The Linder Research Center at The Christ Hospital, Cincinnati, Ohio, United States
🇺🇸The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Phase 1
Recruiting
- Conditions
- Acute Myeloid LeukemiaMyelodysplastic Syndrome
- Interventions
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2024-03-20
- Lead Sponsor
- Edgewood Oncology Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT04243785
- Locations
- 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Memorial Sloan-Kettering Cancer Center, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath